Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM.

J Neurosci. 2004 May 5;24(18):4393-400.

2.
3.

Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.

Sperlágh B, Windisch K, Andó RD, Sylvester Vizi E.

Neurochem Int. 2009 Jun;54(7):452-7. doi: 10.1016/j.neuint.2009.01.017. Epub 2009 Feb 6.

PMID:
19428788
4.
5.
6.

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.

Pistis M, Muntoni AL, Pillolla G, Gessa GL.

Eur J Neurosci. 2002 Jun;15(11):1795-802.

PMID:
12081659
7.

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B.

J Neurosci. 2005 Mar 16;25(11):2874-84.

8.
9.

Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.

Szabo B, Siemes S, Wallmichrath I.

Eur J Neurosci. 2002 Jun;15(12):2057-61.

PMID:
12099913
10.
11.

Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.

Malinen H, Hyytiä P.

Alcohol Clin Exp Res. 2008 Nov;32(11):1976-83. doi: 10.1111/j.1530-0277.2008.00786.x. Epub 2008 Sep 6.

PMID:
18782338
12.

Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo.

Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M.

Psychopharmacology (Berl). 2007 Apr;191(3):843-53. Epub 2007 Feb 16.

PMID:
17334799
13.

Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.

Fawley JA, Hofmann ME, Andresen MC.

J Neurosci. 2014 Jun 11;34(24):8324-32. doi: 10.1523/JNEUROSCI.0315-14.2014.

14.

Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.

Dhawan J, Deng H, Gatley SJ, Makriyannis A, Akinfeleye T, Bruneus M, Dimaio AA, Gifford AN.

Synapse. 2006 Aug;60(2):93-101.

PMID:
16715483
15.

Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.

Tyler K, Hillard CJ, Greenwood-Van Meerveld B.

Eur J Pharmacol. 2000 Dec 8;409(2):207-11.

PMID:
11104836
16.

Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat.

Szabo B, Than M, Thorn D, Wallmichrath I.

J Pharmacol Exp Ther. 2004 Sep;310(3):915-25. Epub 2004 May 3.

17.

The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently.

Polissidis A, Galanopoulos A, Naxakis G, Papahatjis D, Papadopoulou-Daifoti Z, Antoniou K.

Int J Neuropsychopharmacol. 2013 Mar;16(2):393-403. doi: 10.1017/S1461145712000156. Epub 2012 Mar 6.

PMID:
22391102
18.

Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation.

Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM.

J Neurosci. 2007 Jan 24;27(4):791-5.

19.

Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.

Polissidis A, Chouliara O, Galanopoulos A, Naxakis G, Papahatjis D, Papadopoulou-Daifoti Z, Antoniou K.

Behav Brain Res. 2014 Aug 15;270:261-9. doi: 10.1016/j.bbr.2014.05.029. Epub 2014 May 24.

PMID:
24867330
20.

Supplemental Content

Support Center